The US Genetic Testing Market is forecast to increase from USD 4.38 billion in 2025 to USD 23.8 billion by 2035. Market Research Future estimates an 18.44% CAGR during the forecast period, with technological innovation, growing awareness of genetic disorders, and increasing adoption of personalized healthcare supporting market development.

Laboratory services currently hold the largest service category, providing genetic analysis across a broad range of healthcare applications. Diagnostic services are also expanding as healthcare providers increasingly use genetic information for disease assessment, preventive care, and individualized treatment decisions.

Direct-to-consumer genetic testing is another important market trend in the United States. These services allow consumers to obtain information about ancestry, traits, and selected health risks. At the same time, integration with healthcare systems is enabling clinicians to incorporate genetic results into treatment and preventive-care strategies.

Technological developments in next-generation sequencing and bioinformatics are improving the capacity to analyze large volumes of genetic information. Regulatory oversight and consumer-protection measures are also shaping the market by addressing issues related to test accuracy, reliability, and the handling of genetic information.